Filing Details
- Accession Number:
- 0001144204-15-016738
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-03-17 16:18:28
- Reporting Period:
- 2015-03-11
- Filing Date:
- 2015-03-17
- Accepted Time:
- 2015-03-17 16:18:28
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
771856 | Champions Oncology Inc. | CSBR | Biological Products, (No Disgnostic Substances) (2836) | 521401755 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1220630 | Joel Ackerman | C/O Champions Oncology, Inc. One University Place, Suite 307 Hackensack NJ 07601 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-03-11 | 2,710,526 | $0.00 | 3,572,174 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2015-03-11 | 70,826 | $0.00 | 3,643,000 | No | 4 | J | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | J | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Warrant to purchase shares of Common Stock | Acquisiton | 2015-03-11 | 1,490,789 | $0.00 | 1,490,789 | $0.48 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
1,490,789 | 2015-03-11 | 2020-03-11 | No | 4 | A | Direct |
Footnotes
- As a result of the transaction represented in the line above, the 70,826 shares of Common Stock were issued for no consideration pursuant to contractual anti-dilution undertakings of the Issuer in a Securities Purchase Agreement dated March 24, 2011 between the Issuer, the reporting person and certain other investors.
- The warrant was acquired in connection with the purchase of shares of Common Stock pursuant to a Securities Purchase Agreement dated March 13, 2015 between the Issuer, the reporting person and certain other investors for no additional consideration.